Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mei Pharma Inc
(NQ:
MEIP
)
3.110
+0.010 (+0.32%)
Streaming Delayed Price
Updated: 1:39 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mei Pharma Inc
< Previous
1
2
3
4
Next >
MEI Pharma Announces Proposed Public Offering of Common Stock
November 30, 2021
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma and Kyowa Kirin Announce Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib as a Single Agent in Patients with Relapsed or Refractory Follicular Lymphoma
November 30, 2021
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Host Webcast on November 30, 2021 at 8:00 a.m. ET Reporting Data from Ongoing Global Phase 2 TIDAL Study of Zandelisib in Patients with Follicular Lymphoma
November 29, 2021
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors
November 23, 2021
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports First Quarter Fiscal Year 2022 Results and Operational Highlights
November 10, 2021
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma and Kyowa Kirin receive Orphan Drug Designation for Zandelisib for the Treatment of Follicular Lymphoma
November 10, 2021
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Acceptance of Three Abstracts for Presentation at the 63rd Annual American Society of Hematology Annual Meeting
November 04, 2021
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
November 01, 2021
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2021
From
MEI Pharma, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.